Yoon, Seung Kew

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 545

The Etiology of Hepatocellular Carcinoma and Consequences for Treatment

Sanyal, A. J., Yoon, S. K., & Lencioni, R. (2010) · The Oncologist

Hepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus Studies

Cited by 517

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

Sohn, W., Lee, H. W., Lee, S., Lim, J. H., Lee, M. W., Park, C. H., & Yoon, S. K. (2021) · Clinical and Molecular Hepatology

Cancer Risks and FactorsHepatocellular Carcinoma Treatment and Prognosis

Cited by 177

Mitochondrial dysfunction and tissue injury by alcohol, high fat, nonalcoholic substances and pathological conditions through post-translational protein modifications

Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology

Mitochondrial Function and PathologyAlcohol Consumption and Health Effects

Cited by 123